telehealth

News

Novo Nordisk's fling with Hims & Hers ends in a bust-up

The alliance between Novo Nordisk and telehealth firm Hims & Hers for the distribution of GLP-1 agonist weight-loss therapies has ended in acrimony.

News

Digital health firm Omada prices $150m IPO

In another sign of recovery in digital health investing, Omada Health has priced an IPO that could value the company at more than $1.1 billion.

News

Hims & Hers buys Zava to form European beachhead

US telehealth company Hims & Hers has reached a deal to buy its UK counterpart Zava as part of a broader push into Europe.

News

Stethoscope on a tablet with digital globe overlain

Novo Nordisk unleashes Wegovy telehealth blitz

Novo Nordisk has enlisted the aid of major telehealth companies as it tries to dominate the self-pay market for obesity drugs in the US.

News

Lilly adds Alzheimer's to its DTC platform LillyDirect

Eli Lilly's DTC platform LillyDirect has been expanded to include in-person and telehealth services for people in the US living with Alzheimer's.

News

Pharma group slams Hims & Hers over Super Bowl GLP-1 ad

Partnership for Safe Medicines claims the Hims & Hers ad for compounded weight-loss drug semaglutide, due to run during the Super Bowl, is "reckless."

Novo Nordisk's fling with Hims & Hers ends in a bust-up

Digital health firm Omada prices $150m IPO

Hims & Hers buys Zava to form European beachhead

Novo Nordisk unleashes Wegovy telehealth blitz

Lilly adds Alzheimer's to its DTC platform LillyDirect

Pharma group slams Hims & Hers over Super Bowl GLP-1 ad

CHMP backs Novo's haemophilia A drug Frehemgo

Discover a new era of healthcare panel engagement: Grounded ...

telehealth

Editor's Picks